The Latest in Lupus & Connective Tissue Diseases

Rheumatology News

Abnormal bleeding common among youth with joint hypermobility

January 11, 2023

Rheumatology News

Warfarin best for thrombotic antiphospholipid syndrome?

January 11, 2023

Lupus & Connective Tissue Diseases

Rheumatology News

Cardiovascular risk score multipliers suggested for rheumatic diseases

December 21, 2022

Rheumatology News

Vaccination cuts long COVID risk for rheumatic disease patients

December 7, 2022

Rheumatology News

Rituximab raises remission rate in granulomatosis with polyangiitis

November 30, 2022

Rheumatology News

Wide variance described in lab monitoring of conventional synthetic DMARDs

November 28, 2022

Rheumatology News

Sarilumab effective for polymyalgia rheumatica in phase 3 trial

November 22, 2022

Rheumatology News

ACR and EULAR roll out updated antiphospholipid syndrome criteria

November 18, 2022

Lupus & Connective Tissue Diseases

Rheumatology News

New ACR vaccination guideline: Take your best shot

November 18, 2022

Rheumatology News

Doctors urge screening for autoimmune disorders for patients with celiac disease

November 16, 2022

Rheumatology News

Combination therapy shows mixed results for scleroderma-related lung disease

November 15, 2022

Lupus & Connective Tissue Diseases

Rheumatology News

Lower hydroxychloroquine dose for lupus tied to hospitalizations for flares

November 14, 2022

Lupus & Connective Tissue Diseases

Rheumatology News

Remibrutinib safe for Sjögren’s in phase 2

November 14, 2022

Lupus & Connective Tissue Diseases

Rheumatology News

Rituximab ‘a reasonable alternative to cyclophosphamide’ to improve ILD-CTD

November 13, 2022

Lupus & Connective Tissue Diseases

Rheumatology News

Clinical signs differ between children and adults with vasculitis

November 13, 2022